Travis T. Wager

Person

Brookline, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Tricyclic compounds and their use as phosphodiesterase inhibitors
- Patent number 12,049,465
- Issue date Jul 30, 2024
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
- Patent number 11,390,623
- Issue date Jul 19, 2022
- Pfizer Inc.
- Thomas Allen Chappie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
- Patent number 11,312,713
- Issue date Apr 26, 2022
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic substituted imidazo[4,5-c]quinoline derivatives
- Patent number 11,161,844
- Issue date Nov 2, 2021
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
- Patent number 10,738,063
- Issue date Aug 11, 2020
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
- Patent number 10,590,128
- Issue date Mar 17, 2020
- Pfizer, Inc.
- Thomas Allen Chappie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
- Patent number 10,323,042
- Issue date Jun 18, 2019
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidine compounds
- Patent number 10,131,669
- Issue date Nov 20, 2018
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine deriva...
- Patent number 10,039,753
- Issue date Aug 7, 2018
- Pfizer Inc.
- Karen Jean Coffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted...
- Patent number 9,695,171
- Issue date Jul 4, 2017
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors
- Patent number 9,642,855
- Issue date May 9, 2017
- Pfizer Inc.
- Paul Galatsis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibi...
- Patent number 9,156,845
- Issue date Oct 13, 2015
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyridine compounds as casein kinase inhibitors
- Patent number 8,536,164
- Issue date Sep 17, 2013
- Pfizer Inc.
- Todd W. Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as casein kinase inhibitors
- Patent number 8,518,944
- Issue date Aug 27, 2013
- Pfizer Inc.
- Chakrapani Subramanyam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine-3 receptor antagonists
- Patent number 8,389,743
- Issue date Mar 5, 2013
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Toluene sulfonic acid salt of a therapeutic compound and pharmaceut...
- Patent number 8,314,139
- Issue date Nov 20, 2012
- Pfizer Inc.
- Todd W. Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidi...
- Patent number 8,178,574
- Issue date May 15, 2012
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine-3 receptor antagonists
- Patent number 8,158,673
- Issue date Apr 17, 2012
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine-3 receptor antagonists
- Patent number 7,812,040
- Issue date Oct 12, 2010
- Pfizer Inc.
- Travis T Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GSK-3 inhibitors
- Patent number 7,300,943
- Issue date Nov 27, 2007
- Pfizer Inc.
- Travis T. Wager
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors
- Patent number 7,300,944
- Issue date Nov 27, 2007
- Pfizer Inc.
- Daniel W. Kung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NK1 antagonists
- Patent number 7,241,798
- Issue date Jul 10, 2007
- Pfizer Inc.
- Barbara E. Segelstein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Histamine-3 receptor modulators
- Patent number 7,115,600
- Issue date Oct 3, 2006
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
- Publication number 20230146535
- Publication date May 11, 2023
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
- Publication number 20230002386
- Publication date Jan 5, 2023
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS
- Publication number 20210355117
- Publication date Nov 18, 2021
- Pfizer Inc.
- Michael Aaron BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS
- Publication number 20200157098
- Publication date May 21, 2020
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES
- Publication number 20200039977
- Publication date Feb 6, 2020
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS
- Publication number 20190300546
- Publication date Oct 3, 2019
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors
- Publication number 20190263816
- Publication date Aug 29, 2019
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS
- Publication number 20190055262
- Publication date Feb 21, 2019
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS
- Publication number 20190047997
- Publication date Feb 14, 2019
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrazolopyrimidine Compounds
- Publication number 20170204099
- Publication date Jul 20, 2017
- Pfizer Inc.
- Thomas Allen Chappie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine...
- Publication number 20170073343
- Publication date Mar 16, 2017
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-b]PYRIDINES AND 4,5-DISUBSTI...
- Publication number 20170002000
- Publication date Jan 5, 2017
- Pfizer Inc.
- Paul Galatsis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 I...
- Publication number 20150366874
- Publication date Dec 24, 2015
- Pfizer Inc.
- Paul Galatsis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2...
- Publication number 20140005183
- Publication date Jan 2, 2014
- Paul Galatsis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Histamine-3 Receptor Antagonists
- Publication number 20120220568
- Publication date Aug 30, 2012
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL FUSED PYRIDINE COMPOUNDS AS CASEIN KINASE INHIBITORS
- Publication number 20120157440
- Publication date Jun 21, 2012
- Pfizer Inc.
- TODD W. BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compounds As Casein Kinase Inhibitors
- Publication number 20110098272
- Publication date Apr 28, 2011
- Pfizer Inc.
- Chakrapani Subramanyam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolid...
- Publication number 20100256213
- Publication date Oct 7, 2010
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HISTAMINE-3 RECEPTOR ANTAGONISTS
- Publication number 20090131433
- Publication date May 21, 2009
- PFIZER INC.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TOLUENE SULFONIC ACID SALT OF A THERAPEUTIC COMPOUND AND PHARMACEUT...
- Publication number 20080176925
- Publication date Jul 24, 2008
- Pfizer Inc.
- Todd W. Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HISTAMINE-3 RECEPTOR ANTAGONISTS
- Publication number 20080096955
- Publication date Apr 24, 2008
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histamine-3 receptor antagonists
- Publication number 20060069087
- Publication date Mar 30, 2006
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histamine-3 receptor antagonist
- Publication number 20060019998
- Publication date Jan 26, 2006
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK1 antagonists
- Publication number 20050272800
- Publication date Dec 8, 2005
- Pfizer Inc.
- Barbara E. Segelstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histamine-3 receptor modulators
- Publication number 20050171181
- Publication date Aug 4, 2005
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK1 antagonist
- Publication number 20050043354
- Publication date Feb 24, 2005
- Pfizer Inc.
- Travis T. Wager
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GSK-3 inhibitors
- Publication number 20050026946
- Publication date Feb 3, 2005
- Pfizer Inc.
- Travis T. Wager
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors
- Publication number 20040266815
- Publication date Dec 30, 2004
- Pfizer Inc.
- Daniel W. Kung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrazole derivatives
- Publication number 20020103185
- Publication date Aug 1, 2002
- Mark A. Sanner
- C07 - ORGANIC CHEMISTRY

Travis T. Wager

Person

Patents Grantslast 30 patents

Tricyclic compounds and their use as phosphodiesterase inhibitors

6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands

Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors

Cyclic substituted imidazo[4,5-c]quinoline derivatives

6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds

6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands

6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds

Pyrazolopyrimidine compounds

Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine deriva...

3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted...

Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors

4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibi...

Fused pyridine compounds as casein kinase inhibitors

Compounds as casein kinase inhibitors

Histamine-3 receptor antagonists

Toluene sulfonic acid salt of a therapeutic compound and pharmaceut...

Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidi...

Histamine-3 receptor antagonists

Histamine-3 receptor antagonists

GSK-3 inhibitors

Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors

NK1 antagonists

Histamine-3 receptor modulators

Patents Applicationslast 30 patents

TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS

TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS

NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS

6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS

CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES

6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS

Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors

6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS

6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS

Pyrazolopyrimidine Compounds

Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine...

NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-b]PYRIDINES AND 4,5-DISUBSTI...

Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 I...

Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2...

Histamine-3 Receptor Antagonists

NOVEL FUSED PYRIDINE COMPOUNDS AS CASEIN KINASE INHIBITORS

Novel Compounds As Casein Kinase Inhibitors

Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolid...

HISTAMINE-3 RECEPTOR ANTAGONISTS

TOLUENE SULFONIC ACID SALT OF A THERAPEUTIC COMPOUND AND PHARMACEUT...

HISTAMINE-3 RECEPTOR ANTAGONISTS

Histamine-3 receptor antagonists

Histamine-3 receptor antagonist

NK1 antagonists

Histamine-3 receptor modulators

NK1 antagonist

GSK-3 inhibitors

Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors

Pyrazole derivatives